Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02432820 · ClinicalTrials.gov registry record

Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy

A clinical trial, sponsored by Stanford University.

Terminated
Registry status
7
Enrollment target

NCT02432820: Clinical Trial study, sponsored by Stanford University.

NCT02432820 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02432820 was terminated before completion, sponsored by Stanford University.

TERMINATED
Registry status
7 participants
Enrollment target

Study Summary

SPECIFIC STUDY AIMS 1. To evaluate congruence between pelvic anatomical structures segmented on MRI and/or CT scans co-registered with transperineal US scans acquired with an optically and/or electromagnetically tracked matrix array ultrasound transducer. 2. To estimate the achievable accuracy of anatomy tracking based on 3D US matrix-array transducer imaging and grey-level based image registration algorithms.

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2015-04
Est. Completion 2016-09-30

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT02432820

The ClinicalTrials.gov registry entry for NCT02432820 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02432820 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02432820 about?

NCT02432820 is a clinical study titled "Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy". SPECIFIC STUDY AIMS 1. To evaluate congruence between pelvic anatomical structures segmented on MRI and/or CT scans co-registered with transperineal US scans acquired with an optically and/or electromagnetically tracked matrix array ultrasound transducer. 2. To estimate the achievable accuracy of a...

What is the current status of trial NCT02432820?

This trial is currently terminated. The enrollment target is 7 participants. The study started on 2015-04. Estimated completion is 2016-09-30.

Who is sponsoring clinical trial NCT02432820?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.